Cancer BiologybioRxivPreprint
In vitro and in vivo evidences propound therapeutic potential of Lipocalin 2 in cervical carcinoma
N. Dwivedi, T. Mazumder, G. Veeraraghavan…·S. K. Dhar
This study shows that inhibiting LCN2 with a monoclonal antibody reduces cervical cancer cell proliferation, invasion, and tumor growth in vitro and in vivo.
DOI 10.1101/2023.01.13.523914